Table 2.

Primary and secondary arthritic lesions at 21st day in CFA-induced arthritis in rats.

Treatment	Primary lesions (% rise in injected paw volume)	Secondary lesions (% rise in non-injected paw volume)
CFA control	146 ± 4.4	19 ± 0.67
Diclofenac (5 mg kg−1  day−1, p.o.)	83 ± 4.4**	13 ± 0.63**
BA (2 mg kg−1 day−1, p.o.)	113 ± 7.6**	15 ± 0.65**
BA (5 mg kg−1 day−1, p.o.)	109 ± 3.3**	12 ± 0.53**
BA (10 mg kg−1 day−1, p.o.)	91 ± 2.7**	11 ± 0.57**

Data represented in mean ± SEM (n = 6).

**P < .01, compared with control group.